Licensing

Innovation in regulation – the start of a critical conversation

Submitted by Maria on Mon, 09/20/2021 - 13:48

Earlier this year the Minister for Innovation laid out a challenge to health regulators, the Professional Standards Authority, NICE and NHSX during an unprecedented roundtable. If the post-Brexit ambition, as outlined in the government’s Life Sciences Vision, is to provide a world-class regulatory environment that benefits patients and the public while also promoting jobs, growth, and investment, how do we collectively map out the principles and practices needed to achieve these goals? There was a high degree of commi

Extending licences to cover the removal of tissue from the deceased for research

The Human Tissue Act 2004 requires that the removal of tissue from the deceased for research within the scope of the Act must always be licensed, on specified premises, and that specific minimum requirements are met.

This means that if, for example, a person wishes to remove relevant material from a deceased organ donor for research ‘in connection with disorders, or the functioning, of the human body’, the removal must always take place on premises licensed by the HTA for that purpose.